Clinical Trials Browser

Prostatic Neoplasms × Ramucirumab × Clear all

NCT00683475 2014-10-16

A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer

Phase 2 Completed

138 enrolled 17 charts

Prostatic Neoplasms